FDA Approves Asthma Drug Dulera

(Reuters) UPDATED 2010-07-06

The U.S. Food and Drug Administration has approved the combination asthma drug Dulera. The inhaler is approved for people age 12 and older, and contains a combination of a beta agonist and a corticosteroid, much like Advair and Symbicort. Drugmaker Merck says the medication should be available at pharmacies by the end of July.

Read full story >

See all Asthma News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

FDA Approves Asthma Drug Dulera

People who read this also read...

What the community is saying...

2011 Asthma Capitals - The South Is NOT Healthy for People with Asthma

Kathi MacNaughton